Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24794243

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2014 Jun
First author
von Minckwitz G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2014 Jul;11(7):379. doi: 10.1038/nrclinonc.2014.88.
    note
    Source null
    related pmid
    24840078
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2014 Jun;15(7):676-8. doi: 10.1016/S1470-2045(14)70231-1.
    note
    Source null
    related pmid
    24872096
    relationship
    Comment in

Authors and identifiers

  1. name
    von Minckwitz G
    type
    Author
  2. name
    Schneeweiss A
    type
    Author
  3. name
    Loibl S
    type
    Author
  4. name
    Salat C
    type
    Author
  5. name
    Denkert C
    type
    Author
  6. name
    Rezai M
    type
    Author
  7. name
    Blohmer JU
    type
    Author
  8. name
    Jackisch C
    type
    Author
  9. name
    Paepke S
    type
    Author
  10. name
    Gerber B
    type
    Author
  11. name
    Zahm DM
    type
    Author
  12. name
    Kümmel S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    von Minckwitz G
    type
    Author
  2. name
    Schneeweiss A
    type
    Author
  3. name
    Loibl S
    type
    Author
  4. name
    Salat C
    type
    Author
  5. name
    Denkert C
    type
    Author
  6. name
    Rezai M
    type
    Author
  7. name
    Blohmer JU
    type
    Author
  8. name
    Jackisch C
    type
    Author
  9. name
    Paepke S
    type
    Author
  10. name
    Gerber B
    type
    Author
  11. name
    Zahm DM
    type
    Author
  12. name
    Kümmel S
    type
    Author
bibliography ids
  1. nci-bib-c642a813245be65110eb06ac
book metadata
content sha256
2b24899e62e6d47206b07d4eb6a374cbd4bad1e28ef0db4836dddf9a97b3eb01
document type
citation
dois
  1. 10.1016/S1470-2045(14)70160-3
electronic publication date
display
2014 Apr 30
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24794243
immutable id
pubmed:24794243@2b24899e62e6d47206b07d4eb6a374cbd4bad1e28ef0db4836dddf9a97b3eb01
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
7
name
The Lancet. Oncology
nlm unique id
100957246
pages
747-56
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2014 Jul;11(7):379. doi: 10.1038/nrclinonc.2014.88.
    note
    Source null
    related pmid
    24840078
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2014 Jun;15(7):676-8. doi: 10.1016/S1470-2045(14)70231-1.
    note
    Source null
    related pmid
    24872096
    relationship
    Comment in
outcomes validated
false
pmid
24794243
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
510e9f6fcd63fea3b41c29263931c926f1f0ebc3d5c3d38776e251c4151dda8d
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 Jun
precision
month
year
2014
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24794243/
title
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.

Preserved source evidence · Not medical advice